Global Protein Expression Market By System Type, By Offerings, By Application By End User & By Region: Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031

Report ID :AMI-1668 | Category : Healthcare | Published Date : August, 2023 | Pages : 402 | Format :PDF

Global Protein Expression Market Recorded Sales Worth US$ 3.01 Billion in 2022, Growing at an Estimated CAGR of 12.5% From 2023-2031. 

Protein expression is the process by which cells synthesize proteins based on genetic instructions. It involves translating the information encoded in DNA into functional proteins. The central dogma of molecular biology outlines this process: DNA is transcribed into RNA, and then RNA is translated into proteins. In research and biotechnology, protein expression is manipulated to produce specific proteins of interest for various purposes, such as studying their functions, developing therapies, or producing industrial enzymes. Techniques like recombinant DNA technology enable the insertion of foreign genes into host cells, allowing them to express desired proteins. This field plays a vital role in understanding cellular processes, advancing medical science, and producing valuable bioproducts.

Among system types, mammalian cell expression systems have historically been dominating the protein expression market. These systems are preferred for their ability to produce complex, properly folded proteins that closely resemble human proteins. They are often used in the production of therapeutic proteins and biopharmaceuticals, contributing to their dominance in the market.

COVID-19 Impact Analysis on Global Protein Expression Market

The urgent need for understanding the SARS-CoV-2 virus and developing treatments, vaccines led to a surge in protein expression research. Researchers aimed to produce viral proteins for diagnostic tests, therapeutic development, and vaccine candidates. This increased demand for protein expression market tools, reagents, and expertise.

Global Protein Expression Market Revenue & Forecast, (US$ Million), 2015 – 2031

Global Protein Expression Market

The expanding biopharmaceutical sector demands efficient protein expression systems for producing therapeutic proteins and antibodies. Global biopharmaceutical sales reached over $340 billion in 2022, with protein-based therapeutics accounting for a substantial share. The increasing need for personalized medicine and targeted therapies is driving research into novel proteins, boosting the demand for advanced protein expression technologies to meet these complex requirements. The complexity of optimizing protein expression systems and the associated costs can be a restraint. Developing and scaling up expression platforms often requires considerable time, resources, and expertise. For instance, recombinant protein production's complexity led to an estimated 30-40% failure rate in academic labs. High costs associated with sophisticated expression systems, reagents, and equipment can limit accessibility, particularly for smaller research entities or institutions with budget constraints. However, the protein expression market is expected to gain momentum in the years to come irrespective of a few hurdles that might likely hinder its growth.

Therapeutic applications have historically dominated the protein expression market. The biopharmaceutical industry heavily relies on protein expression technologies to produce therapeutic proteins, monoclonal antibodies, and other biologics. This sector has been experiencing substantial growth, with biologics accounting for over 30% of the total pharmaceutical market. The increasing demand for personalized medicine, targeted therapies, and biopharmaceutical products has contributed to the dominance of therapeutic applications.

North America registered for major chunk of the revenue in 2022 in the global protein expression market. The US biopharmaceutical industry accounted for over a third of global biopharmaceutical sales. The National Institutes of Health (NIH) funding for biotechnology research exceeded $37 billion. With a mature life sciences ecosystem, North America's dominance is evident through extensive research collaborations, well-funded projects, and a concentration of leading biotech and pharmaceutical companies.

Competitive Landscape

The report provides both, qualitative and quantitative research of global protein expression market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the global protein expression market are

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories
  • Corning Incorporated
  • Danaher
  • FUJIFILM Irvine Scientific
  • GenScript
  • Lonza Group
  • Merck KGaA
  • QIAGEN
  • Sartorius AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Other Industry Participants

Global Protein Expression Market:

By System Type

  • Mammalian Cell Expression Systems
  • Prokaryotic Expression Systems
  • Insect Cell Expression Systems
  • Yeast Expression Systems
  • Cell-Free Expression Systems
  • Algal-Based Expression Systems

By Offerings

  • Reagents
  • Expression Vectors
  • Competent Cells
  • Instruments
  • Services

By Application

  • Therapeutic Applications
  • Research Applications
  • Industrial Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations & Contract Development and Manufacturing Organizations (CROS & CDMOS)
  • Other End Users

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)


Table of Contents

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2021

1.2.2. Base Year: 2022

1.2.3. Forecast Years: 2023 – 2031

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Protein Expression Market

6.    Market Synopsis:  Protein Expression Market

7.    Protein Expression Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in Protein Expression Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Protein Expression Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Protein Expression Market

7.8. PESTEL Analysis

8.    Global Protein Expression Market Analysis and Forecasts, 2023 - 2031

8.1. Overview

8.1.1. Global Protein Expression Market Revenue (US$ Mn)

8.2. Global Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

8.2.1. Mammalian Cell Expression Systems

8.2.1.1.    Definition

8.2.1.2.    Market Estimation and Penetration, 2015 - 2022

8.2.1.3.    Market Forecast, 2023 - 2031

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.1.5.    Regional Bifurcation

8.2.1.5.1.    North America

8.2.1.5.1.1. Market Estimation, 2015 - 2022

8.2.1.5.1.2. Market Forecast, 2023 - 2031

8.2.1.5.2.    Europe

8.2.1.5.2.1. Market Estimation, 2015 - 2022

8.2.1.5.2.2. Market Forecast, 2023 - 2031

8.2.1.5.3.    Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 - 2022

8.2.1.5.3.2. Market Forecast, 2023 - 2031

8.2.1.5.4.    Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 - 2022

8.2.1.5.4.2. Market Forecast, 2023 - 2031

8.2.1.5.5.    Latin America

8.2.1.5.5.1. Market Estimation, 2015 - 2022

8.2.1.5.5.2. Market Forecast, 2023 - 2031

8.2.2. Prokaryotic Expression Systems

8.2.2.1.    Definition

8.2.2.2.    Market Estimation and Penetration, 2015 - 2022

8.2.2.3.    Market Forecast, 2023 - 2031

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.2.5.    Regional Bifurcation

8.2.2.5.1.    North America

8.2.2.5.1.1. Market Estimation, 2015 - 2022

8.2.2.5.1.2. Market Forecast, 2023 - 2031

8.2.2.5.2.    Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2022

8.2.2.5.2.2. Market Forecast, 2023 - 2031

8.2.2.5.3.    Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2022

8.2.2.5.3.2. Market Forecast, 2023 - 2031

8.2.2.5.4.    Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2022

8.2.2.5.4.2. Market Forecast, 2023 - 2031

8.2.2.5.5.    Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2022

8.2.2.5.5.2. Market Forecast, 2023 - 2031

8.2.3. Insect Cell Expression Systems

8.2.3.1.    Definition

8.2.3.2.    Market Estimation and Penetration, 2015 - 2022

8.2.3.3.    Market Forecast, 2023 - 2031

8.2.3.4.    Compound Annual Growth Rate (CAGR)

8.2.3.5.    Regional Bifurcation

8.2.3.5.1.    North America

8.2.3.5.1.1. Market Estimation, 2015 - 2022

8.2.3.5.1.2. Market Forecast, 2023 - 2031

8.2.3.5.2.    Europe

8.2.3.5.2.1. Market Estimation, 2015 - 2022

8.2.3.5.2.2. Market Forecast, 2023 - 2031

8.2.3.5.3.    Asia Pacific

8.2.3.5.3.1. Market Estimation, 2015 - 2022

8.2.3.5.3.2. Market Forecast, 2023 - 2031

8.2.3.5.4.    Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2015 - 2022

8.2.3.5.4.2. Market Forecast, 2023 - 2031

8.2.3.5.5.    Latin America

8.2.3.5.5.1. Market Estimation, 2015 - 2022

8.2.3.5.5.2. Market Forecast, 2023 - 2031

8.2.4. Yeast Expression Systems

8.2.4.1.    Definition

8.2.4.2.    Market Estimation and Penetration, 2015 - 2022

8.2.4.3.    Market Forecast, 2023 - 2031

8.2.4.4.    Compound Annual Growth Rate (CAGR)

8.2.4.5.    Regional Bifurcation

8.2.4.5.1.    North America

8.2.4.5.1.1. Market Estimation, 2015 - 2022

8.2.4.5.1.2. Market Forecast, 2023 - 2031

8.2.4.5.2.    Europe

8.2.4.5.2.1. Market Estimation, 2015 - 2022

8.2.4.5.2.2. Market Forecast, 2023 - 2031

8.2.4.5.3.    Asia Pacific

8.2.4.5.3.1. Market Estimation, 2015 - 2022

8.2.4.5.3.2. Market Forecast, 2023 - 2031

8.2.4.5.4.    Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2015 - 2022

8.2.4.5.4.2. Market Forecast, 2023 - 2031

8.2.4.5.5.    Latin America

8.2.4.5.5.1. Market Estimation, 2015 - 2022

8.2.4.5.5.2. Market Forecast, 2023 - 2031

8.2.5. Cell-Free Expression Systems

8.2.5.1.    Definition

8.2.5.2.    Market Estimation and Penetration, 2015 - 2022

8.2.5.3.    Market Forecast, 2023 - 2031

8.2.5.4.    Compound Annual Growth Rate (CAGR)

8.2.5.5.    Regional Bifurcation

8.2.5.5.1.    North America

8.2.5.5.1.1. Market Estimation, 2015 - 2022

8.2.5.5.1.2. Market Forecast, 2023 - 2031

8.2.5.5.2.    Europe

8.2.5.5.2.1. Market Estimation, 2015 - 2022

8.2.5.5.2.2. Market Forecast, 2023 - 2031

8.2.5.5.3.    Asia Pacific

8.2.5.5.3.1. Market Estimation, 2015 - 2022

8.2.5.5.3.2. Market Forecast, 2023 - 2031

8.2.5.5.4.    Middle East and Africa

8.2.5.5.4.1. Market Estimation, 2015 - 2022

8.2.5.5.4.2. Market Forecast, 2023 - 2031

8.2.5.5.5.    Latin America

8.2.5.5.5.1. Market Estimation, 2015 - 2022

8.2.5.5.5.2. Market Forecast, 2023 - 2031

8.2.6. Algal-Based Expression Systems

8.2.6.1.    Definition

8.2.6.2.    Market Estimation and Penetration, 2015 - 2022

8.2.6.3.    Market Forecast, 2023 - 2031

8.2.6.4.    Compound Annual Growth Rate (CAGR)

8.2.6.5.    Regional Bifurcation

8.2.6.5.1.    North America

8.2.6.5.1.1. Market Estimation, 2015 - 2022

8.2.6.5.1.2. Market Forecast, 2023 - 2031

8.2.6.5.2.    Europe

8.2.6.5.2.1. Market Estimation, 2015 - 2022

8.2.6.5.2.2. Market Forecast, 2023 - 2031

8.2.6.5.3.    Asia Pacific

8.2.6.5.3.1. Market Estimation, 2015 - 2022

8.2.6.5.3.2. Market Forecast, 2023 - 2031

8.2.6.5.4.    Middle East and Africa

8.2.6.5.4.1. Market Estimation, 2015 - 2022

8.2.6.5.4.2. Market Forecast, 2023 - 2031

8.2.6.5.5.    Latin America

8.2.6.5.5.1. Market Estimation, 2015 - 2022

8.2.6.5.5.2. Market Forecast, 2023 - 2031

8.3. Key Segment for Channeling Investments

8.3.1. By System Type

9.    Global Protein Expression Market Analysis and Forecasts, 2023 - 2031

9.1. Overview

9.2. Global Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

9.2.1. Reagents

9.2.1.1.    Definition

9.2.1.2.    Market Estimation and Penetration, 2015 - 2022

9.2.1.3.    Market Forecast, 2023 - 2031

9.2.1.4.    Compound Annual Growth Rate (CAGR)

9.2.1.5.    Regional Bifurcation

9.2.1.5.1.    North America

9.2.1.5.1.1. Market Estimation, 2015 - 2022

9.2.1.5.1.2. Market Forecast, 2023 - 2031

9.2.1.5.2.    Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2022

9.2.1.5.2.2. Market Forecast, 2023 - 2031

9.2.1.5.3.    Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2022

9.2.1.5.3.2. Market Forecast, 2023 - 2031

9.2.1.5.4.    Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2022

9.2.1.5.4.2. Market Forecast, 2023 - 2031

9.2.1.5.5.    Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2022

9.2.1.5.5.2. Market Forecast, 2023 - 2031

9.2.2. Expression Vectors

9.2.2.1.    Definition

9.2.2.2.    Market Estimation and Penetration, 2015 - 2022

9.2.2.3.    Market Forecast, 2023 - 2031

9.2.2.4.    Compound Annual Growth Rate (CAGR)

9.2.2.5.    Regional Bifurcation

9.2.2.5.1.    North America

9.2.2.5.1.1. Market Estimation, 2015 - 2022

9.2.2.5.1.2. Market Forecast, 2023 - 2031

9.2.2.5.2.    Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2022

9.2.2.5.2.2. Market Forecast, 2023 - 2031

9.2.2.5.3.    Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2022

9.2.2.5.3.2. Market Forecast, 2023 - 2031

9.2.2.5.4.    Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2022

9.2.2.5.4.2. Market Forecast, 2023 - 2031

9.2.2.5.5.    Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2022

9.2.2.5.5.2. Market Forecast, 2023 - 2031

9.2.3. Competent Cells

9.2.3.1.    Definition

9.2.3.2.    Market Estimation and Penetration, 2015 - 2022

9.2.3.3.    Market Forecast, 2023 - 2031

9.2.3.4.    Compound Annual Growth Rate (CAGR)

9.2.3.5.    Regional Bifurcation

9.2.3.5.1.    North America

9.2.3.5.1.1. Market Estimation, 2015 - 2022

9.2.3.5.1.2. Market Forecast, 2023 - 2031

9.2.3.5.2.    Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2022

9.2.3.5.2.2. Market Forecast, 2023 - 2031

9.2.3.5.3.    Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2022

9.2.3.5.3.2. Market Forecast, 2023 - 2031

9.2.3.5.4.    Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2022

9.2.3.5.4.2. Market Forecast, 2023 - 2031

9.2.3.5.5.    Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2022

9.2.3.5.5.2. Market Forecast, 2023 - 2031

9.2.4. Instruments

9.2.4.1.    Definition

9.2.4.2.    Market Estimation and Penetration, 2015 - 2022

9.2.4.3.    Market Forecast, 2023 - 2031

9.2.4.4.    Compound Annual Growth Rate (CAGR)

9.2.4.5.    Regional Bifurcation

9.2.4.5.1.    North America

9.2.4.5.1.1. Market Estimation, 2015 - 2022

9.2.4.5.1.2. Market Forecast, 2023 - 2031

9.2.4.5.2.    Europe

9.2.4.5.2.1. Market Estimation, 2015 - 2022

9.2.4.5.2.2. Market Forecast, 2023 - 2031

9.2.4.5.3.    Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 - 2022

9.2.4.5.3.2. Market Forecast, 2023 - 2031

9.2.4.5.4.    Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 - 2022

9.2.4.5.4.2. Market Forecast, 2023 - 2031

9.2.4.5.5.    Latin America

9.2.4.5.5.1. Market Estimation, 2015 - 2022

9.2.4.5.5.2. Market Forecast, 2023 - 2031

9.2.5. Services

9.2.5.1.    Definition

9.2.5.2.    Market Estimation and Penetration, 2015 - 2022

9.2.5.3.    Market Forecast, 2023 - 2031

9.2.5.4.    Compound Annual Growth Rate (CAGR)

9.2.5.5.    Regional Bifurcation

9.2.5.5.1.    North America

9.2.5.5.1.1. Market Estimation, 2015 - 2022

9.2.5.5.1.2. Market Forecast, 2023 - 2031

9.2.5.5.2.    Europe

9.2.5.5.2.1. Market Estimation, 2015 - 2022

9.2.5.5.2.2. Market Forecast, 2023 - 2031

9.2.5.5.3.    Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 - 2022

9.2.5.5.3.2. Market Forecast, 2023 - 2031

9.2.5.5.4.    Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 - 2022

9.2.5.5.4.2. Market Forecast, 2023 - 2031

9.2.5.5.5.    Latin America

9.2.5.5.5.1. Market Estimation, 2015 - 2022

9.2.5.5.5.2. Market Forecast, 2023 - 2031

9.3. Key Segment for Channeling Investments

9.3.1. By Offerings

10. Global Protein Expression Market Analysis and Forecasts, 2023 - 2031

10.1. Overview

10.2. Global Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

10.2.1. Therapeutic Applications

10.2.1.1.  Definition

10.2.1.2.  Market Estimation and Penetration, 2015 - 2022

10.2.1.3.  Market Forecast, 2023 - 2031

10.2.1.4.  Compound Annual Growth Rate (CAGR)

10.2.1.5.  Regional Bifurcation

10.2.1.5.1.  North America

10.2.1.5.1.1. Market Estimation, 2015 - 2022

10.2.1.5.1.2. Market Forecast, 2023 - 2031

10.2.1.5.2.  Europe

10.2.1.5.2.1. Market Estimation, 2015 - 2022

10.2.1.5.2.2. Market Forecast, 2023 - 2031

10.2.1.5.3.  Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 - 2022

10.2.1.5.3.2. Market Forecast, 2023 - 2031

10.2.1.5.4.  Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 - 2022

10.2.1.5.4.2. Market Forecast, 2023 - 2031

10.2.1.5.5.  Latin America

10.2.1.5.5.1. Market Estimation, 2015 - 2022

10.2.1.5.5.2. Market Forecast, 2023 - 2031

10.2.2. Research Applications

10.2.2.1.  Definition

10.2.2.2.  Market Estimation and Penetration, 2015 - 2022

10.2.2.3.  Market Forecast, 2023 - 2031

10.2.2.4.  Compound Annual Growth Rate (CAGR)

10.2.2.5.  Regional Bifurcation

10.2.2.5.1.  North America

10.2.2.5.1.1. Market Estimation, 2015 - 2022

10.2.2.5.1.2. Market Forecast, 2023 - 2031

10.2.2.5.2.  Europe

10.2.2.5.2.1. Market Estimation, 2015 - 2022

10.2.2.5.2.2. Market Forecast, 2023 - 2031

10.2.2.5.3.  Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 - 2022

10.2.2.5.3.2. Market Forecast, 2023 - 2031

10.2.2.5.4.  Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 - 2022

10.2.2.5.4.2. Market Forecast, 2023 - 2031

10.2.2.5.5.  Latin America

10.2.2.5.5.1. Market Estimation, 2015 - 2022

10.2.2.5.5.2. Market Forecast, 2023 - 2031

10.2.3. Industrial Applications

10.2.3.1.  Definition

10.2.3.2.  Market Estimation and Penetration, 2015 - 2022

10.2.3.3.  Market Forecast, 2023 - 2031

10.2.3.4.  Compound Annual Growth Rate (CAGR)

10.2.3.5.  Regional Bifurcation

10.2.3.5.1.  North America

10.2.3.5.1.1. Market Estimation, 2015 - 2022

10.2.3.5.1.2. Market Forecast, 2023 - 2031

10.2.3.5.2.  Europe

10.2.3.5.2.1. Market Estimation, 2015 - 2022

10.2.3.5.2.2. Market Forecast, 2023 - 2031

10.2.3.5.3.  Asia Pacific

10.2.3.5.3.1. Market Estimation, 2015 - 2022

10.2.3.5.3.2. Market Forecast, 2023 - 2031

10.2.3.5.4.  Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2015 - 2022

10.2.3.5.4.2. Market Forecast, 2023 - 2031

10.2.3.5.5.  Latin America

10.2.3.5.5.1. Market Estimation, 2015 - 2022

10.2.3.5.5.2. Market Forecast, 2023 - 2031

10.3. Key Segment for Channeling Investments

10.3.1. By Application

11. Global Protein Expression Market Analysis and Forecasts, 2023 - 2031

11.1. Overview

11.2. Global Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

11.2.1. Pharmaceutical and Biotechnology Companies

11.2.1.1.  Definition

11.2.1.2.  Market Estimation and Penetration, 2015 - 2022

11.2.1.3.  Market Forecast, 2023 - 2031

11.2.1.4.  Compound Annual Growth Rate (CAGR)

11.2.1.5.  Regional Bifurcation

11.2.1.5.1.  North America

11.2.1.5.1.1. Market Estimation, 2015 - 2022

11.2.1.5.1.2. Market Forecast, 2023 - 2031

11.2.1.5.2.  Europe

11.2.1.5.2.1. Market Estimation, 2015 - 2022

11.2.1.5.2.2. Market Forecast, 2023 - 2031

11.2.1.5.3.  Asia Pacific

11.2.1.5.3.1. Market Estimation, 2015 - 2022

11.2.1.5.3.2. Market Forecast, 2023 - 2031

11.2.1.5.4.  Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2015 - 2022

11.2.1.5.4.2. Market Forecast, 2023 - 2031

11.2.1.5.5.  Latin America

11.2.1.5.5.1. Market Estimation, 2015 - 2022

11.2.1.5.5.2. Market Forecast, 2023 - 2031

11.2.2. Academic Research Institutes

11.2.2.1.  Definition

11.2.2.2.  Market Estimation and Penetration, 2015 - 2022

11.2.2.3.  Market Forecast, 2023 - 2031

11.2.2.4.  Compound Annual Growth Rate (CAGR)

11.2.2.5.  Regional Bifurcation

11.2.2.5.1.  North America

11.2.2.5.1.1. Market Estimation, 2015 - 2022

11.2.2.5.1.2. Market Forecast, 2023 - 2031

11.2.2.5.2.  Europe

11.2.2.5.2.1. Market Estimation, 2015 - 2022

11.2.2.5.2.2. Market Forecast, 2023 - 2031

11.2.2.5.3.  Asia Pacific

11.2.2.5.3.1. Market Estimation, 2015 - 2022

11.2.2.5.3.2. Market Forecast, 2023 - 2031

11.2.2.5.4.  Middle East and Africa

11.2.2.5.4.1. Market Estimation, 2015 - 2022

11.2.2.5.4.2. Market Forecast, 2023 - 2031

11.2.2.5.5.  Latin America

11.2.2.5.5.1. Market Estimation, 2015 - 2022

11.2.2.5.5.2. Market Forecast, 2023 - 2031

11.2.3. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

11.2.3.1.  Definition

11.2.3.2.  Market Estimation and Penetration, 2015 - 2022

11.2.3.3.  Market Forecast, 2023 - 2031

11.2.3.4.  Compound Annual Growth Rate (CAGR)

11.2.3.5.  Regional Bifurcation

11.2.3.5.1.  North America

11.2.3.5.1.1. Market Estimation, 2015 - 2022

11.2.3.5.1.2. Market Forecast, 2023 - 2031

11.2.3.5.2.  Europe

11.2.3.5.2.1. Market Estimation, 2015 - 2022

11.2.3.5.2.2. Market Forecast, 2023 - 2031

11.2.3.5.3.  Asia Pacific

11.2.3.5.3.1. Market Estimation, 2015 - 2022

11.2.3.5.3.2. Market Forecast, 2023 - 2031

11.2.3.5.4.  Middle East and Africa

11.2.3.5.4.1. Market Estimation, 2015 - 2022

11.2.3.5.4.2. Market Forecast, 2023 - 2031

11.2.3.5.5.  Latin America

11.2.3.5.5.1. Market Estimation, 2015 - 2022

11.2.3.5.5.2. Market Forecast, 2023 - 2031

11.2.4. Other End Users

11.2.4.1.  Definition

11.2.4.2.  Market Estimation and Penetration, 2015 - 2022

11.2.4.3.  Market Forecast, 2023 - 2031

11.2.4.4.  Compound Annual Growth Rate (CAGR)

11.2.4.5.  Regional Bifurcation

11.2.4.5.1.  North America

11.2.4.5.1.1. Market Estimation, 2015 - 2022

11.2.4.5.1.2. Market Forecast, 2023 - 2031

11.2.4.5.2.  Europe

11.2.4.5.2.1. Market Estimation, 2015 - 2022

11.2.4.5.2.2. Market Forecast, 2023 - 2031

11.2.4.5.3.  Asia Pacific

11.2.4.5.3.1. Market Estimation, 2015 - 2022

11.2.4.5.3.2. Market Forecast, 2023 - 2031

11.2.4.5.4.  Middle East and Africa

11.2.4.5.4.1. Market Estimation, 2015 - 2022

11.2.4.5.4.2. Market Forecast, 2023 - 2031

11.2.4.5.5.  Latin America

11.2.4.5.5.1. Market Estimation, 2015 - 2022

11.2.4.5.5.2. Market Forecast, 2023 - 2031

11.3. Key Segment for Channeling Investments

11.3.1. By End User

12. North America Protein Expression Market Analysis and Forecasts, 2023 - 2031

12.1. Overview

12.1.1. North America Protein Expression Market Revenue (US$ Mn)

12.2. North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

12.2.1. Mammalian Cell Expression Systems

12.2.2. Prokaryotic Expression Systems

12.2.3. Insect Cell Expression Systems

12.2.4. Yeast Expression Systems

12.2.5. Cell-Free Expression Systems

12.2.6. Algal-Based Expression Systems

12.3. North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

12.3.1. Reagents

12.3.2. Expression Vectors

12.3.3. Competent Cells

12.3.4. Instruments

12.3.5. Services

12.4. North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

12.4.1. Therapeutic Applications

12.4.2. Research Applications

12.4.3. Industrial Applications

12.5. North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

12.5.1. Pharmaceutical and Biotechnology Companies

12.5.2. Academic Research Institutes

12.5.3. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

12.5.4. Other End Users

12.6. North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. U.S

12.6.1.1.  U.S Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

12.6.1.1.1.  Mammalian Cell Expression Systems

12.6.1.1.2.  Prokaryotic Expression Systems

12.6.1.1.3.  Insect Cell Expression Systems

12.6.1.1.4.  Yeast Expression Systems

12.6.1.1.5.  Cell-Free Expression Systems

12.6.1.1.6.  Algal-Based Expression Systems

12.6.1.2.  U.S Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

12.6.1.2.1.  Reagents

12.6.1.2.2.  Expression Vectors

12.6.1.2.3.  Competent Cells

12.6.1.2.4.  Instruments

12.6.1.2.5.  Services

12.6.1.3.  U.S Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

12.6.1.3.1.  Therapeutic Applications

12.6.1.3.2.  Research Applications

12.6.1.3.3.  Industrial Applications

12.6.1.4.  U.S Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

12.6.1.4.1.  Pharmaceutical and Biotechnology Companies

12.6.1.4.2.  Academic Research Institutes

12.6.1.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

12.6.1.4.4.  Other End Users

12.6.2. Canada

12.6.2.1.  Canada Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

12.6.2.1.1.  Mammalian Cell Expression Systems

12.6.2.1.2.  Prokaryotic Expression Systems

12.6.2.1.3.  Insect Cell Expression Systems

12.6.2.1.4.  Yeast Expression Systems

12.6.2.1.5.  Cell-Free Expression Systems

12.6.2.1.6.  Algal-Based Expression Systems

12.6.2.2.  Canada Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

12.6.2.2.1.  Reagents

12.6.2.2.2.  Expression Vectors

12.6.2.2.3.  Competent Cells

12.6.2.2.4.  Instruments

12.6.2.2.5.  Services

12.6.2.3.  Canada Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

12.6.2.3.1.  Therapeutic Applications

12.6.2.3.2.  Research Applications

12.6.2.3.3.  Industrial Applications

12.6.2.4.  Canada Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

12.6.2.4.1.  Pharmaceutical and Biotechnology Companies

12.6.2.4.2.  Academic Research Institutes

12.6.2.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

12.6.2.4.4.  Other End Users

12.6.3. Mexico

12.6.3.1.  Mexico Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

12.6.3.1.1.  Mammalian Cell Expression Systems

12.6.3.1.2.  Prokaryotic Expression Systems

12.6.3.1.3.  Insect Cell Expression Systems

12.6.3.1.4.  Yeast Expression Systems

12.6.3.1.5.  Cell-Free Expression Systems

12.6.3.1.6.  Algal-Based Expression Systems

12.6.3.2.  Mexico Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

12.6.3.2.1.  Reagents

12.6.3.2.2.  Expression Vectors

12.6.3.2.3.  Competent Cells

12.6.3.2.4.  Instruments

12.6.3.2.5.  Services

12.6.3.3.  Mexico Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

12.6.3.3.1.  Therapeutic Applications

12.6.3.3.2.  Research Applications

12.6.3.3.3.  Industrial Applications

12.6.3.4.  Mexico Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

12.6.3.4.1.  Pharmaceutical and Biotechnology Companies

12.6.3.4.2.  Academic Research Institutes

12.6.3.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

12.6.3.4.4.  Other End Users

12.6.4. Rest of North America

12.6.4.1.  Rest of North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

12.6.4.1.1.  Mammalian Cell Expression Systems

12.6.4.1.2.  Prokaryotic Expression Systems

12.6.4.1.3.  Insect Cell Expression Systems

12.6.4.1.4.  Yeast Expression Systems

12.6.4.1.5.  Cell-Free Expression Systems

12.6.4.1.6.  Algal-Based Expression Systems

12.6.4.2.  Rest of North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

12.6.4.2.1.  Reagents

12.6.4.2.2.  Expression Vectors

12.6.4.2.3.  Competent Cells

12.6.4.2.4.  Instruments

12.6.4.2.5.  Services

12.6.4.3.  Rest of North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

12.6.4.3.1.  Therapeutic Applications

12.6.4.3.2.  Research Applications

12.6.4.3.3.  Industrial Applications

12.6.4.4.  Rest of North America Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

12.6.4.4.1.  Pharmaceutical and Biotechnology Companies

12.6.4.4.2.  Academic Research Institutes

12.6.4.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

12.6.4.4.4.  Other End Users

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By System Type

12.7.3. By Offerings

12.7.4. By Application

12.7.5. By End User

13. Europe Protein Expression Market Analysis and Forecasts, 2023 - 2031

13.1. Overview

13.1.1. Europe Protein Expression Market Revenue (US$ Mn)

13.2. Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.2.1. Mammalian Cell Expression Systems

13.2.2. Prokaryotic Expression Systems

13.2.3. Insect Cell Expression Systems

13.2.4. Yeast Expression Systems

13.2.5. Cell-Free Expression Systems

13.2.6. Algal-Based Expression Systems

13.3. Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.3.1. Reagents

13.3.2. Expression Vectors

13.3.3. Competent Cells

13.3.4. Instruments

13.3.5. Services

13.4. Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.4.1. Therapeutic Applications

13.4.2. Research Applications

13.4.3. Industrial Applications

13.5. Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.5.1. Pharmaceutical and Biotechnology Companies

13.5.2. Academic Research Institutes

13.5.3. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.5.4. Other End Users

13.6. Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. France

13.6.1.1.  France Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.6.1.1.1.  Mammalian Cell Expression Systems

13.6.1.1.2.  Prokaryotic Expression Systems

13.6.1.1.3.  Insect Cell Expression Systems

13.6.1.1.4.  Yeast Expression Systems

13.6.1.1.5.  Cell-Free Expression Systems

13.6.1.1.6.  Algal-Based Expression Systems

13.6.1.2.  France Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.6.1.2.1.  Reagents

13.6.1.2.2.  Expression Vectors

13.6.1.2.3.  Competent Cells

13.6.1.2.4.  Instruments

13.6.1.2.5.  Services

13.6.1.3.  France Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.6.1.3.1.  Therapeutic Applications

13.6.1.3.2.  Research Applications

13.6.1.3.3.  Industrial Applications

13.6.1.4.  France Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.6.1.4.1.  Pharmaceutical and Biotechnology Companies

13.6.1.4.2.  Academic Research Institutes

13.6.1.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.6.1.4.4.  Other End Users

13.6.2. The UK

13.6.2.1.  The UK Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.6.2.1.1.  Mammalian Cell Expression Systems

13.6.2.1.2.  Prokaryotic Expression Systems

13.6.2.1.3.  Insect Cell Expression Systems

13.6.2.1.4.  Yeast Expression Systems

13.6.2.1.5.  Cell-Free Expression Systems

13.6.2.1.6.  Algal-Based Expression Systems

13.6.2.2.  The UK Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.6.2.2.1.  Reagents

13.6.2.2.2.  Expression Vectors

13.6.2.2.3.  Competent Cells

13.6.2.2.4.  Instruments

13.6.2.2.5.  Services

13.6.2.3.  The UK Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.6.2.3.1.  Therapeutic Applications

13.6.2.3.2.  Research Applications

13.6.2.3.3.  Industrial Applications

13.6.2.4.  The UK Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.6.2.4.1.  Pharmaceutical and Biotechnology Companies

13.6.2.4.2.  Academic Research Institutes

13.6.2.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.6.2.4.4.  Other End Users

13.6.3. Spain

13.6.3.1.  Spain Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.6.3.1.1.  Mammalian Cell Expression Systems

13.6.3.1.2.  Prokaryotic Expression Systems

13.6.3.1.3.  Insect Cell Expression Systems

13.6.3.1.4.  Yeast Expression Systems

13.6.3.1.5.  Cell-Free Expression Systems

13.6.3.1.6.  Algal-Based Expression Systems

13.6.3.2.  Spain Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.6.3.2.1.  Reagents

13.6.3.2.2.  Expression Vectors

13.6.3.2.3.  Competent Cells

13.6.3.2.4.  Instruments

13.6.3.2.5.  Services

13.6.3.3.  Spain Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.6.3.3.1.  Therapeutic Applications

13.6.3.3.2.  Research Applications

13.6.3.3.3.  Industrial Applications

13.6.3.4.  Spain Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.6.3.4.1.  Pharmaceutical and Biotechnology Companies

13.6.3.4.2.  Academic Research Institutes

13.6.3.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.6.3.4.4.  Other End Users

13.6.4. Germany

13.6.4.1.  Germany Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.6.4.1.1.  Mammalian Cell Expression Systems

13.6.4.1.2.  Prokaryotic Expression Systems

13.6.4.1.3.  Insect Cell Expression Systems

13.6.4.1.4.  Yeast Expression Systems

13.6.4.1.5.  Cell-Free Expression Systems

13.6.4.1.6.  Algal-Based Expression Systems

13.6.4.2.  Germany Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.6.4.2.1.  Reagents

13.6.4.2.2.  Expression Vectors

13.6.4.2.3.  Competent Cells

13.6.4.2.4.  Instruments

13.6.4.2.5.  Services

13.6.4.3.  Germany Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.6.4.3.1.  Therapeutic Applications

13.6.4.3.2.  Research Applications

13.6.4.3.3.  Industrial Applications

13.6.4.4.  Germany Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.6.4.4.1.  Pharmaceutical and Biotechnology Companies

13.6.4.4.2.  Academic Research Institutes

13.6.4.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.6.4.4.4.  Other End Users

13.6.5. Italy

13.6.5.1.  Italy Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.6.5.1.1.  Mammalian Cell Expression Systems

13.6.5.1.2.  Prokaryotic Expression Systems

13.6.5.1.3.  Insect Cell Expression Systems

13.6.5.1.4.  Yeast Expression Systems

13.6.5.1.5.  Cell-Free Expression Systems

13.6.5.1.6.  Algal-Based Expression Systems

13.6.5.2.  Italy Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.6.5.2.1.  Reagents

13.6.5.2.2.  Expression Vectors

13.6.5.2.3.  Competent Cells

13.6.5.2.4.  Instruments

13.6.5.2.5.  Services

13.6.5.3.  Italy Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.6.5.3.1.  Therapeutic Applications

13.6.5.3.2.  Research Applications

13.6.5.3.3.  Industrial Applications

13.6.5.4.  Italy Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.6.5.4.1.  Pharmaceutical and Biotechnology Companies

13.6.5.4.2.  Academic Research Institutes

13.6.5.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.6.5.4.4.  Other End Users

13.6.6. Nordic Countries

13.6.6.1.  Nordic Countries Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.6.6.1.1.  Mammalian Cell Expression Systems

13.6.6.1.2.  Prokaryotic Expression Systems

13.6.6.1.3.  Insect Cell Expression Systems

13.6.6.1.4.  Yeast Expression Systems

13.6.6.1.5.  Cell-Free Expression Systems

13.6.6.1.6.  Algal-Based Expression Systems

13.6.6.2.  Nordic Countries Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.6.6.2.1.  Reagents

13.6.6.2.2.  Expression Vectors

13.6.6.2.3.  Competent Cells

13.6.6.2.4.  Instruments

13.6.6.2.5.  Services

13.6.6.3.  Nordic Countries Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.6.6.3.1.  Therapeutic Applications

13.6.6.3.2.  Research Applications

13.6.6.3.3.  Industrial Applications

13.6.6.4.  Nordic Countries Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.6.6.4.1.  Pharmaceutical and Biotechnology Companies

13.6.6.4.2.  Academic Research Institutes

13.6.6.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.6.6.4.4.  Other End Users

13.6.6.5.  Nordic Countries Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country

13.6.6.5.1.  Denmark

13.6.6.5.2.  Finland

13.6.6.5.3.  Iceland

13.6.6.5.4.  Sweden

13.6.6.5.5.  Norway

13.6.7. Benelux Union

13.6.7.1.  Benelux Union Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.6.7.1.1.  Mammalian Cell Expression Systems

13.6.7.1.2.  Prokaryotic Expression Systems

13.6.7.1.3.  Insect Cell Expression Systems

13.6.7.1.4.  Yeast Expression Systems

13.6.7.1.5.  Cell-Free Expression Systems

13.6.7.1.6.  Algal-Based Expression Systems

13.6.7.2.  Benelux Union Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.6.7.2.1.  Reagents

13.6.7.2.2.  Expression Vectors

13.6.7.2.3.  Competent Cells

13.6.7.2.4.  Instruments

13.6.7.2.5.  Services

13.6.7.3.  Benelux Union Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.6.7.3.1.  Therapeutic Applications

13.6.7.3.2.  Research Applications

13.6.7.3.3.  Industrial Applications

13.6.7.4.  Benelux Union Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.6.7.4.1.  Pharmaceutical and Biotechnology Companies

13.6.7.4.2.  Academic Research Institutes

13.6.7.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.6.7.4.4.  Other End Users

13.6.7.5.  Benelux Union Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country

13.6.7.5.1.  Belgium

13.6.7.5.2.  The Netherlands

13.6.7.5.3.  Luxembourg

13.6.8. Rest of Europe

13.6.8.1.  Rest of Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

13.6.8.1.1.  Mammalian Cell Expression Systems

13.6.8.1.2.  Prokaryotic Expression Systems

13.6.8.1.3.  Insect Cell Expression Systems

13.6.8.1.4.  Yeast Expression Systems

13.6.8.1.5.  Cell-Free Expression Systems

13.6.8.1.6.  Algal-Based Expression Systems

13.6.8.2.  Rest of Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

13.6.8.2.1.  Reagents

13.6.8.2.2.  Expression Vectors

13.6.8.2.3.  Competent Cells

13.6.8.2.4.  Instruments

13.6.8.2.5.  Services

13.6.8.3.  Rest of Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

13.6.8.3.1.  Therapeutic Applications

13.6.8.3.2.  Research Applications

13.6.8.3.3.  Industrial Applications

13.6.8.4.  Rest of Europe Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

13.6.8.4.1.  Pharmaceutical and Biotechnology Companies

13.6.8.4.2.  Academic Research Institutes

13.6.8.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

13.6.8.4.4.  Other End Users

13.7. Key Segment for Channeling Investments

13.7.1. By Country

13.7.2. By System Type

13.7.3. By Offerings

13.7.4. By Application

13.7.5. By End User

14. Asia Pacific Protein Expression Market Analysis and Forecasts, 2023 - 2031

14.1. Overview

14.1.1. Asia Pacific Protein Expression Market Revenue (US$ Mn)

14.2. Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.2.1. Mammalian Cell Expression Systems

14.2.2. Prokaryotic Expression Systems

14.2.3. Insect Cell Expression Systems

14.2.4. Yeast Expression Systems

14.2.5. Cell-Free Expression Systems

14.2.6. Algal-Based Expression Systems

14.3. Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.3.1. Reagents

14.3.2. Expression Vectors

14.3.3. Competent Cells

14.3.4. Instruments

14.3.5. Services

14.4. Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.4.1. Therapeutic Applications

14.4.2. Research Applications

14.4.3. Industrial Applications

14.5. Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.5.1. Pharmaceutical and Biotechnology Companies

14.5.2. Academic Research Institutes

14.5.3. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.5.4. Other End Users

14.6. Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country

14.6.1. China

14.6.1.1.  China Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.6.1.1.1.  Mammalian Cell Expression Systems

14.6.1.1.2.  Prokaryotic Expression Systems

14.6.1.1.3.  Insect Cell Expression Systems

14.6.1.1.4.  Yeast Expression Systems

14.6.1.1.5.  Cell-Free Expression Systems

14.6.1.1.6.  Algal-Based Expression Systems

14.6.1.2.  China Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.6.1.2.1.  Reagents

14.6.1.2.2.  Expression Vectors

14.6.1.2.3.  Competent Cells

14.6.1.2.4.  Instruments

14.6.1.2.5.  Services

14.6.1.3.  China Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.6.1.3.1.  Therapeutic Applications

14.6.1.3.2.  Research Applications

14.6.1.3.3.  Industrial Applications

14.6.1.4.  China Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.6.1.4.1.  Pharmaceutical and Biotechnology Companies

14.6.1.4.2.  Academic Research Institutes

14.6.1.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.6.1.4.4.  Other End Users

14.6.2. Japan

14.6.2.1.  Japan Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.6.2.1.1.  Mammalian Cell Expression Systems

14.6.2.1.2.  Prokaryotic Expression Systems

14.6.2.1.3.  Insect Cell Expression Systems

14.6.2.1.4.  Yeast Expression Systems

14.6.2.1.5.  Cell-Free Expression Systems

14.6.2.1.6.  Algal-Based Expression Systems

14.6.2.2.  Japan Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.6.2.2.1.  Reagents

14.6.2.2.2.  Expression Vectors

14.6.2.2.3.  Competent Cells

14.6.2.2.4.  Instruments

14.6.2.2.5.  Services

14.6.2.3.  Japan Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.6.2.3.1.  Therapeutic Applications

14.6.2.3.2.  Research Applications

14.6.2.3.3.  Industrial Applications

14.6.2.4.  Japan Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.6.2.4.1.  Pharmaceutical and Biotechnology Companies

14.6.2.4.2.  Academic Research Institutes

14.6.2.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.6.2.4.4.  Other End Users

14.6.3. India

14.6.3.1.  India Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.6.3.1.1.  Mammalian Cell Expression Systems

14.6.3.1.2.  Prokaryotic Expression Systems

14.6.3.1.3.  Insect Cell Expression Systems

14.6.3.1.4.  Yeast Expression Systems

14.6.3.1.5.  Cell-Free Expression Systems

14.6.3.1.6.  Algal-Based Expression Systems

14.6.3.2.  India Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.6.3.2.1.  Reagents

14.6.3.2.2.  Expression Vectors

14.6.3.2.3.  Competent Cells

14.6.3.2.4.  Instruments

14.6.3.2.5.  Services

14.6.3.3.  India Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.6.3.3.1.  Therapeutic Applications

14.6.3.3.2.  Research Applications

14.6.3.3.3.  Industrial Applications

14.6.3.4.  India Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.6.3.4.1.  Pharmaceutical and Biotechnology Companies

14.6.3.4.2.  Academic Research Institutes

14.6.3.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.6.3.4.4.  Other End Users

14.6.4. New Zealand

14.6.4.1.  New Zealand Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.6.4.1.1.  Mammalian Cell Expression Systems

14.6.4.1.2.  Prokaryotic Expression Systems

14.6.4.1.3.  Insect Cell Expression Systems

14.6.4.1.4.  Yeast Expression Systems

14.6.4.1.5.  Cell-Free Expression Systems

14.6.4.1.6.  Algal-Based Expression Systems

14.6.4.2.  New Zealand Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.6.4.2.1.  Reagents

14.6.4.2.2.  Expression Vectors

14.6.4.2.3.  Competent Cells

14.6.4.2.4.  Instruments

14.6.4.2.5.  Services

14.6.4.3.  New Zealand Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.6.4.3.1.  Therapeutic Applications

14.6.4.3.2.  Research Applications

14.6.4.3.3.  Industrial Applications

14.6.4.4.  New Zealand Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.6.4.4.1.  Pharmaceutical and Biotechnology Companies

14.6.4.4.2.  Academic Research Institutes

14.6.4.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.6.4.4.4.  Other End Users

14.6.5. Australia

14.6.5.1.  Australia Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.6.5.1.1.  Mammalian Cell Expression Systems

14.6.5.1.2.  Prokaryotic Expression Systems

14.6.5.1.3.  Insect Cell Expression Systems

14.6.5.1.4.  Yeast Expression Systems

14.6.5.1.5.  Cell-Free Expression Systems

14.6.5.1.6.  Algal-Based Expression Systems

14.6.5.2.  Australia Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.6.5.2.1.  Reagents

14.6.5.2.2.  Expression Vectors

14.6.5.2.3.  Competent Cells

14.6.5.2.4.  Instruments

14.6.5.2.5.  Services

14.6.5.3.  Australia Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.6.5.3.1.  Therapeutic Applications

14.6.5.3.2.  Research Applications

14.6.5.3.3.  Industrial Applications

14.6.5.4.  Australia Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.6.5.4.1.  Pharmaceutical and Biotechnology Companies

14.6.5.4.2.  Academic Research Institutes

14.6.5.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.6.5.4.4.  Other End Users

14.6.6. South Korea

14.6.6.1.  South Korea Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.6.6.1.1.  Mammalian Cell Expression Systems

14.6.6.1.2.  Prokaryotic Expression Systems

14.6.6.1.3.  Insect Cell Expression Systems

14.6.6.1.4.  Yeast Expression Systems

14.6.6.1.5.  Cell-Free Expression Systems

14.6.6.1.6.  Algal-Based Expression Systems

14.6.6.2.  South Korea Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.6.6.2.1.  Reagents

14.6.6.2.2.  Expression Vectors

14.6.6.2.3.  Competent Cells

14.6.6.2.4.  Instruments

14.6.6.2.5.  Services

14.6.6.3.  South Korea Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.6.6.3.1.  Therapeutic Applications

14.6.6.3.2.  Research Applications

14.6.6.3.3.  Industrial Applications

14.6.6.4.  South Korea Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.6.6.4.1.  Pharmaceutical and Biotechnology Companies

14.6.6.4.2.  Academic Research Institutes

14.6.6.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.6.6.4.4.  Other End Users

14.6.7. Southeast Asia

14.6.7.1.  Southeast Asia Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.6.7.1.1.  Mammalian Cell Expression Systems

14.6.7.1.2.  Prokaryotic Expression Systems

14.6.7.1.3.  Insect Cell Expression Systems

14.6.7.1.4.  Yeast Expression Systems

14.6.7.1.5.  Cell-Free Expression Systems

14.6.7.1.6.  Algal-Based Expression Systems

14.6.7.2.  Southeast Asia Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.6.7.2.1.  Reagents

14.6.7.2.2.  Expression Vectors

14.6.7.2.3.  Competent Cells

14.6.7.2.4.  Instruments

14.6.7.2.5.  Services

14.6.7.3.  Southeast Asia Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.6.7.3.1.  Therapeutic Applications

14.6.7.3.2.  Research Applications

14.6.7.3.3.  Industrial Applications

14.6.7.4.  Southeast Asia Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.6.7.4.1.  Pharmaceutical and Biotechnology Companies

14.6.7.4.2.  Academic Research Institutes

14.6.7.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.6.7.4.4.  Other End Users

14.6.7.5.  Southeast Asia Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country

14.6.7.5.1.  Indonesia

14.6.7.5.2.  Thailand

14.6.7.5.3.  Malaysia

14.6.7.5.4.  Singapore

14.6.7.5.5.  Rest of Southeast Asia

14.6.8. Rest of Asia Pacific

14.6.8.1.  Rest of Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

14.6.8.1.1.  Mammalian Cell Expression Systems

14.6.8.1.2.  Prokaryotic Expression Systems

14.6.8.1.3.  Insect Cell Expression Systems

14.6.8.1.4.  Yeast Expression Systems

14.6.8.1.5.  Cell-Free Expression Systems

14.6.8.1.6.  Algal-Based Expression Systems

14.6.8.2.  Rest of Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

14.6.8.2.1.  Reagents

14.6.8.2.2.  Expression Vectors

14.6.8.2.3.  Competent Cells

14.6.8.2.4.  Instruments

14.6.8.2.5.  Services

14.6.8.3.  Rest of Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

14.6.8.3.1.  Therapeutic Applications

14.6.8.3.2.  Research Applications

14.6.8.3.3.  Industrial Applications

14.6.8.4.  Rest of Asia Pacific Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

14.6.8.4.1.  Pharmaceutical and Biotechnology Companies

14.6.8.4.2.  Academic Research Institutes

14.6.8.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

14.6.8.4.4.  Other End Users

14.7. Key Segment for Channeling Investments

14.7.1. By Country

14.7.2. By System Type

14.7.3. By Offerings

14.7.4. By Application

14.7.5. By End User

15. Middle East and Africa Protein Expression Market Analysis and Forecasts, 2023 - 2031

15.1. Overview

15.1.1. Middle East and Africa Protein Expression Market Revenue (US$ Mn)

15.2. Middle East and Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

15.2.1. Mammalian Cell Expression Systems

15.2.2. Prokaryotic Expression Systems

15.2.3. Insect Cell Expression Systems

15.2.4. Yeast Expression Systems

15.2.5. Cell-Free Expression Systems

15.2.6. Algal-Based Expression Systems

15.3. Middle East and Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

15.3.1. Reagents

15.3.2. Expression Vectors

15.3.3. Competent Cells

15.3.4. Instruments

15.3.5. Services

15.4. Middle East and Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

15.4.1. Therapeutic Applications

15.4.2. Research Applications

15.4.3. Industrial Applications

15.5. Middle East and Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

15.5.1. Pharmaceutical and Biotechnology Companies

15.5.2. Academic Research Institutes

15.5.3. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

15.5.4. Other End Users

15.6. Middle East and Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country

15.6.1. Saudi Arabia

15.6.1.1.  Saudi Arabia Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

15.6.1.1.1.  Mammalian Cell Expression Systems

15.6.1.1.2.  Prokaryotic Expression Systems

15.6.1.1.3.  Insect Cell Expression Systems

15.6.1.1.4.  Yeast Expression Systems

15.6.1.1.5.  Cell-Free Expression Systems

15.6.1.1.6.  Algal-Based Expression Systems

15.6.1.2.  Saudi Arabia Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

15.6.1.2.1.  Reagents

15.6.1.2.2.  Expression Vectors

15.6.1.2.3.  Competent Cells

15.6.1.2.4.  Instruments

15.6.1.2.5.  Services

15.6.1.3.  Saudi Arabia Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

15.6.1.3.1.  Therapeutic Applications

15.6.1.3.2.  Research Applications

15.6.1.3.3.  Industrial Applications

15.6.1.4.  Saudi Arabia Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

15.6.1.4.1.  Pharmaceutical and Biotechnology Companies

15.6.1.4.2.  Academic Research Institutes

15.6.1.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

15.6.1.4.4.  Other End Users

15.6.2. UAE

15.6.2.1.  UAE Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

15.6.2.1.1.  Mammalian Cell Expression Systems

15.6.2.1.2.  Prokaryotic Expression Systems

15.6.2.1.3.  Insect Cell Expression Systems

15.6.2.1.4.  Yeast Expression Systems

15.6.2.1.5.  Cell-Free Expression Systems

15.6.2.1.6.  Algal-Based Expression Systems

15.6.2.2.  UAE Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

15.6.2.2.1.  Reagents

15.6.2.2.2.  Expression Vectors

15.6.2.2.3.  Competent Cells

15.6.2.2.4.  Instruments

15.6.2.2.5.  Services

15.6.2.3.  UAE Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

15.6.2.3.1.  Therapeutic Applications

15.6.2.3.2.  Research Applications

15.6.2.3.3.  Industrial Applications

15.6.2.4.  UAE Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

15.6.2.4.1.  Pharmaceutical and Biotechnology Companies

15.6.2.4.2.  Academic Research Institutes

15.6.2.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

15.6.2.4.4.  Other End Users

15.6.3. Egypt

15.6.3.1.  Egypt Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

15.6.3.1.1.  Mammalian Cell Expression Systems

15.6.3.1.2.  Prokaryotic Expression Systems

15.6.3.1.3.  Insect Cell Expression Systems

15.6.3.1.4.  Yeast Expression Systems

15.6.3.1.5.  Cell-Free Expression Systems

15.6.3.1.6.  Algal-Based Expression Systems

15.6.3.2.  Egypt Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

15.6.3.2.1.  Reagents

15.6.3.2.2.  Expression Vectors

15.6.3.2.3.  Competent Cells

15.6.3.2.4.  Instruments

15.6.3.2.5.  Services

15.6.3.3.  Egypt Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

15.6.3.3.1.  Therapeutic Applications

15.6.3.3.2.  Research Applications

15.6.3.3.3.  Industrial Applications

15.6.3.4.  Egypt Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

15.6.3.4.1.  Pharmaceutical and Biotechnology Companies

15.6.3.4.2.  Academic Research Institutes

15.6.3.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

15.6.3.4.4.  Other End Users

15.6.4. Kuwait

15.6.4.1.  Kuwait Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

15.6.4.1.1.  Mammalian Cell Expression Systems

15.6.4.1.2.  Prokaryotic Expression Systems

15.6.4.1.3.  Insect Cell Expression Systems

15.6.4.1.4.  Yeast Expression Systems

15.6.4.1.5.  Cell-Free Expression Systems

15.6.4.1.6.  Algal-Based Expression Systems

15.6.4.2.  Kuwait Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

15.6.4.2.1.  Reagents

15.6.4.2.2.  Expression Vectors

15.6.4.2.3.  Competent Cells

15.6.4.2.4.  Instruments

15.6.4.2.5.  Services

15.6.4.3.  Kuwait Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

15.6.4.3.1.  Therapeutic Applications

15.6.4.3.2.  Research Applications

15.6.4.3.3.  Industrial Applications

15.6.4.4.  Kuwait Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

15.6.4.4.1.  Pharmaceutical and Biotechnology Companies

15.6.4.4.2.  Academic Research Institutes

15.6.4.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

15.6.4.4.4.  Other End Users

15.6.5. South Africa

15.6.5.1.  South Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

15.6.5.1.1.  Mammalian Cell Expression Systems

15.6.5.1.2.  Prokaryotic Expression Systems

15.6.5.1.3.  Insect Cell Expression Systems

15.6.5.1.4.  Yeast Expression Systems

15.6.5.1.5.  Cell-Free Expression Systems

15.6.5.1.6.  Algal-Based Expression Systems

15.6.5.2.  South Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

15.6.5.2.1.  Reagents

15.6.5.2.2.  Expression Vectors

15.6.5.2.3.  Competent Cells

15.6.5.2.4.  Instruments

15.6.5.2.5.  Services

15.6.5.3.  South Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

15.6.5.3.1.  Therapeutic Applications

15.6.5.3.2.  Research Applications

15.6.5.3.3.  Industrial Applications

15.6.5.4.  South Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

15.6.5.4.1.  Pharmaceutical and Biotechnology Companies

15.6.5.4.2.  Academic Research Institutes

15.6.5.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

15.6.5.4.4.  Other End Users

15.6.6. Rest of Middle East & Africa

15.6.6.1.  Rest of Middle East & Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

15.6.6.1.1.  Mammalian Cell Expression Systems

15.6.6.1.2.  Prokaryotic Expression Systems

15.6.6.1.3.  Insect Cell Expression Systems

15.6.6.1.4.  Yeast Expression Systems

15.6.6.1.5.  Cell-Free Expression Systems

15.6.6.1.6.  Algal-Based Expression Systems

15.6.6.2.  Rest of Middle East & Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

15.6.6.2.1.  Reagents

15.6.6.2.2.  Expression Vectors

15.6.6.2.3.  Competent Cells

15.6.6.2.4.  Instruments

15.6.6.2.5.  Services

15.6.6.3.  Rest of Middle East & Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

15.6.6.3.1.  Therapeutic Applications

15.6.6.3.2.  Research Applications

15.6.6.3.3.  Industrial Applications

15.6.6.4.  Rest of Middle East & Africa Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

15.6.6.4.1.  Pharmaceutical and Biotechnology Companies

15.6.6.4.2.  Academic Research Institutes

15.6.6.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

15.6.6.4.4.  Other End Users

15.7. Key Segment for Channeling Investments

15.7.1. By Country

15.7.2. By System Type

15.7.3. By Offerings

15.7.4. By Application

15.7.5. By End User

16. Latin America Protein Expression Market Analysis and Forecasts, 2023 - 2031

16.1. Overview

16.1.1. Latin America Protein Expression Market Revenue (US$ Mn)

16.2. Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

16.2.1. Mammalian Cell Expression Systems

16.2.2. Prokaryotic Expression Systems

16.2.3. Insect Cell Expression Systems

16.2.4. Yeast Expression Systems

16.2.5. Cell-Free Expression Systems

16.2.6. Algal-Based Expression Systems

16.3. Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

16.3.1. Reagents

16.3.2. Expression Vectors

16.3.3. Competent Cells

16.3.4. Instruments

16.3.5. Services

16.4. Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

16.4.1. Therapeutic Applications

16.4.2. Research Applications

16.4.3. Industrial Applications

16.5. Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

16.5.1. Pharmaceutical and Biotechnology Companies

16.5.2. Academic Research Institutes

16.5.3. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

16.5.4. Other End Users

16.6. Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Country

16.6.1. Brazil

16.6.1.1.  Brazil Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

16.6.1.1.1.  Mammalian Cell Expression Systems

16.6.1.1.2.  Prokaryotic Expression Systems

16.6.1.1.3.  Insect Cell Expression Systems

16.6.1.1.4.  Yeast Expression Systems

16.6.1.1.5.  Cell-Free Expression Systems

16.6.1.1.6.  Algal-Based Expression Systems

16.6.1.2.  Brazil Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

16.6.1.2.1.  Reagents

16.6.1.2.2.  Expression Vectors

16.6.1.2.3.  Competent Cells

16.6.1.2.4.  Instruments

16.6.1.2.5.  Services

16.6.1.3.  Brazil Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

16.6.1.3.1.  Therapeutic Applications

16.6.1.3.2.  Research Applications

16.6.1.3.3.  Industrial Applications

16.6.1.4.  Brazil Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

16.6.1.4.1.  Pharmaceutical and Biotechnology Companies

16.6.1.4.2.  Academic Research Institutes

16.6.1.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

16.6.1.4.4.  Other End Users

16.6.2. Argentina

16.6.2.1.  Argentina Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

16.6.2.1.1.  Mammalian Cell Expression Systems

16.6.2.1.2.  Prokaryotic Expression Systems

16.6.2.1.3.  Insect Cell Expression Systems

16.6.2.1.4.  Yeast Expression Systems

16.6.2.1.5.  Cell-Free Expression Systems

16.6.2.1.6.  Algal-Based Expression Systems

16.6.2.2.  Argentina Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

16.6.2.2.1.  Reagents

16.6.2.2.2.  Expression Vectors

16.6.2.2.3.  Competent Cells

16.6.2.2.4.  Instruments

16.6.2.2.5.  Services

16.6.2.3.  Argentina Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

16.6.2.3.1.  Therapeutic Applications

16.6.2.3.2.  Research Applications

16.6.2.3.3.  Industrial Applications

16.6.2.4.  Argentina Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

16.6.2.4.1.  Pharmaceutical and Biotechnology Companies

16.6.2.4.2.  Academic Research Institutes

16.6.2.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

16.6.2.4.4.  Other End Users

16.6.3. Rest of Latin America

16.6.3.1.  Rest of Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By System Type

16.6.3.1.1.  Mammalian Cell Expression Systems

16.6.3.1.2.  Prokaryotic Expression Systems

16.6.3.1.3.  Insect Cell Expression Systems

16.6.3.1.4.  Yeast Expression Systems

16.6.3.1.5.  Cell-Free Expression Systems

16.6.3.1.6.  Algal-Based Expression Systems

16.6.3.2.  Rest of Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Offerings

16.6.3.2.1.  Reagents

16.6.3.2.2.  Expression Vectors

16.6.3.2.3.  Competent Cells

16.6.3.2.4.  Instruments

16.6.3.2.5.  Services

16.6.3.3.  Rest of Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By Application

16.6.3.3.1.  Therapeutic Applications

16.6.3.3.2.  Research Applications

16.6.3.3.3.  Industrial Applications

16.6.3.4.  Rest of Latin America Protein Expression Market Revenue (US$ Mn) and Forecasts, By End User

16.6.3.4.1.  Pharmaceutical and Biotechnology Companies

16.6.3.4.2.  Academic Research Institutes

16.6.3.4.3.  Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)

16.6.3.4.4.  Other End Users

16.7. Key Segment for Channeling Investments

16.7.1. By Country

16.7.2. By System Type

16.7.3. By Offerings

16.7.4. By Application

16.7.5. By End User

17. Competitive Benchmarking

17.1. Brand Benchmarking

17.2. Market Share Analysis, 2022

17.3. Global Presence and Growth Strategies

17.3.1. Mergers and Acquisitions

17.3.2. Product Launches

17.3.3. Investments Trends

17.3.4. R&D Initiatives

18. Player Profiles

18.1. Agilent Technologies, Inc.

18.1.1. Company Details

18.1.2. Company Overview

18.1.3. Product Offerings

18.1.4. Key Developments

18.1.5. Financial Analysis

18.1.6. SWOT Analysis

18.1.7. Business Strategies

18.2. Bio-Rad Laboratories, Inc.

18.2.1. Company Details

18.2.2. Company Overview

18.2.3. Product Offerings

18.2.4. Key Developments

18.2.5. Financial Analysis

18.2.6. SWOT Analysis

18.2.7. Business Strategies

18.3. Charles River Laboratories

18.3.1. Company Details

18.3.2. Company Overview

18.3.3. Product Offerings

18.3.4. Key Developments

18.3.5. Financial Analysis

18.3.6. SWOT Analysis

18.3.7. Business Strategies

18.4. Corning Incorporated

18.4.1. Company Details

18.4.2. Company Overview

18.4.3. Product Offerings

18.4.4. Key Developments

18.4.5. Financial Analysis

18.4.6. SWOT Analysis

18.4.7. Business Strategies

18.5. Danaher

18.5.1. Company Details

18.5.2. Company Overview

18.5.3. Product Offerings

18.5.4. Key Developments

18.5.5. Financial Analysis

18.5.6. SWOT Analysis

18.5.7. Business Strategies

18.6. FUJIFILM Irvine Scientific

18.6.1. Company Details

18.6.2. Company Overview

18.6.3. Product Offerings

18.6.4. Key Developments

18.6.5. Financial Analysis

18.6.6. SWOT Analysis

18.6.7. Business Strategies

18.7. GenScript

18.7.1. Company Details

18.7.2. Company Overview

18.7.3. Product Offerings

18.7.4. Key Developments

18.7.5. Financial Analysis

18.7.6. SWOT Analysis

18.7.7. Business Strategies

18.8. Lonza Group

18.8.1. Company Details

18.8.2. Company Overview

18.8.3. Product Offerings

18.8.4. Key Developments

18.8.5. Financial Analysis

18.8.6. SWOT Analysis

18.8.7. Business Strategies

18.9. Merck KGaA

18.9.1. Company Details

18.9.2. Company Overview

18.9.3. Product Offerings

18.9.4. Key Developments

18.9.5. Financial Analysis

18.9.6. SWOT Analysis

18.9.7. Business Strategies

18.10. QIAGEN

18.10.1. Company Details

18.10.2. Company Overview

18.10.3. Product Offerings

18.10.4. Key Developments

18.10.5. Financial Analysis

18.10.6. SWOT Analysis

18.10.7. Business Strategies

18.11. Sartorius AG

18.11.1. Company Details

18.11.2. Company Overview

18.11.3. Product Offerings

18.11.4. Key Developments

18.11.5. Financial Analysis

18.11.6. SWOT Analysis

18.11.7. Business Strategies

18.12. Takara Bio Inc.

18.12.1. Company Details

18.12.2. Company Overview

18.12.3. Product Offerings

18.12.4. Key Developments

18.12.5. Financial Analysis

18.12.6. SWOT Analysis

18.12.7. Business Strategies

18.13. Thermo Fisher Scientific Inc.

18.13.1. Company Details

18.13.2. Company Overview

18.13.3. Product Offerings

18.13.4. Key Developments

18.13.5. Financial Analysis

18.13.6. SWOT Analysis

18.13.7. Business Strategies

18.14. Other Industry Participants

19. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com